Mexico has one of the highest burdens of Chronic Kidney Disease (CKD) in the world, driven by widespread type 2 diabetes and hypertension, and by a distinct form of CKD of undetermined cause seen among agricultural workers in several states. As kidney function declines gradually over months or years, standard nephrology care in Mexico focuses on controlling the underlying cause, slowing further decline, and, for advanced disease, preparing patients for dialysis or transplant. Many Mexican patients look internationally for a second opinion and for access to advanced diagnostics; Stem Cell Cure India offers an evaluation to help patients understand whether stem cell therapy may be relevant to their specific stage of kidney disease, always alongside — never instead of — nephrology care.
Patients with earlier-stage CKD who are not yet on dialysis, or who are already on dialysis but want to explore additional supportive options alongside their ongoing nephrology care, sometimes look into regenerative approaches such as stem cell therapy. With dialysis capacity stretched in parts of Mexico and transplant waiting lists that can run long, patients often want a specialist evaluation that combines updated diagnostics with a candid opinion on whether a regenerative approach is worth considering in their particular stage of disease.
Dr. Tyagi leads regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients being evaluated for kidney and other regenerative conditions.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients travelling from Mexico before and during their stem cell therapy journey.
Mesenchymal Stem Cells (MSCs) are being studied for their potential anti-inflammatory effects and a possible role in supporting kidney function in some stages of chronic kidney disease research. It is important to set realistic expectations: stem cell therapy is not established as a treatment that reverses significant, established kidney damage, and it is not a substitute for dialysis or transplant in end-stage renal disease. This approach is explored as a complement to — not a replacement for — standard nephrology management of the underlying cause.
Suitability depends on the stage and cause of kidney disease, and current dialysis status. Before travelling from Mexico, our team reviews:
No. Stem cell therapy is not established as a treatment that reverses significant kidney damage, and it cannot replace dialysis or transplant for end-stage renal disease. It is explored as an option that may help support kidney function at earlier stages, alongside standard nephrology care.
This varies by CKD stage and underlying cause. Share your creatinine/eGFR results and underlying diagnosis so our team can give an initial opinion before you plan travel.
Recent creatinine/eGFR results, urine albumin-creatinine ratio, kidney ultrasound, and details of the underlying cause and dialysis status if applicable.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up and treatment plan required.
Yes. Once an evaluation is confirmed, we provide the invitation letter and supporting documents needed to apply for an Indian Medical Visa, and guide you through each step.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
